Bristol Myers Squibb CEO and Key Executive Team

• Chris Boerner

  Chief Executive Officer and Director
• Sandra Leung

  Executive Vice President, General Counsel
• David Elkins

  Executive Vice President and Chief Financial Officer
• Samit Hirawat

  Executive Vice President, Chief Medical Officer, Drug Development
• Pamela Fisher

  Vice President, Chief Diversity and Inclusion Officer
• Greg Meyers

  Executive Vice President, Chief Digital & Technology Officer
• Adam Lenkowsky

  Executive Vice President, Chief Commercialization Officer
• Robert Plenge

  Executive Vice President, Chief Research Officer, Head of Research
• Sunil Patel

  Executive Director, Immunology, Cardiovascular and Neuroscience Transactions
• Kim Jablonski

  Chief Compliance & Ethics Officer
• Amanda Poole

  Executive Vice President, Chief Human Resources Officer
• Neil Bence

  Vice President, Head of Oncology Discovery, San Diego Site Head
• Peter S. Paine III

  Senior Vice President, Chief of Staff to the CEO
• Peter J. Arduini

  Director
• Nisha Zaidi

  Vice President, Global Alliances
• Pat Gliha

  Executive Director, Global Alliances
• Martin Crook

  Vice President, Corporate Development Assessments
• Wendy Bartie

  Senior Vice President, US Oncology and Hematology
• Cari Gallman

  Executive Vice President, Corporate Affairs
• Dennis Wysocki

  Executive Director, Global Alliances
• Mario Ceravolo

  Director of Finance, Italy
• Lynelle Hoch

  President, Cell Therapy Organization
• Michael Ellis

  Senior Vice President, Head, Small Molecule Drug Discovery
• Anuradha Connor

  Senior Director, Business Development, Search & Evaluation, Hematology
• Jill Sanford

  Executive Director, Global Alliances
• Richard Hargreaves

  Senior Vice President, Neuroscience Thematic Research Center
• Mehul Shah

  Executive Director, Business Development Transactions
• Anna Rivkin

  VP, Business Development, Transactions
• Piyush Durani

  Executive Director, Oncology, Search & Evaluation
• Catalina Vargas

  SVP, Global Supply Chain
• Karin Shanahan

  Executive Vice President, Global Product Development & Supply
• Avnish Kapoor

  Executive Director, Business Development, Search & Evaluation, Oncology
• Ashley Koegel

  Medical Director, Early Clinical Development
• Patty McDonnell

  Senior Director
• Johan Oslob

  Scientific Senior Director
• Leanne Peiser

  Executive Director, Immuno-Oncology and Cellular Therapy Translational Development
• John L. Damonti

  President - Bristol Myers Squibb Foundation and Vice President, Patient Assistance BMS Company
• Michael Pourdehnad

  Vice President, Head of Early Clinical Development for Hematology, Oncology and Cell Therapy
• Venkat Sethuraman

  Senior Vice President, Global Biometrics and Data Sciences
• Amy Sehnert

  Vice President, Global Program Lead CV Transition Assets
• Emma Lees

  Senior Vice President, Research and Early Development and Head, Mechanisms of Cancer Resistance TRC
• Sandro Imbesi

  Director GRS Italy
• Estelle Vester-Blokland

  SVP, Medical Head International Markets
• Mark Rolfe

  Senior Vice President, Oncogenesis Thematic Research Center
• Erica Horwitz

  Vice President, M&A
• Jennifer Schwartz

  VP, Business Development, Oncology, Hematology & Cell Therapy Transactions
• Michael May

  Countrywide Medical Director, Germany, Global Medical
• Myrtle Davis

  Scientific Vice President, Discovery Toxicology
• Tim Power

  Vice President, Head of Investor Relations
• Tunde Bello

  Senior Vice President, Head of Clinical Pharmacology, Pharmacometrics, Disposition, and Bioanalysis

Source: bms.com, bms.com, news.bms.com, bms.com, bms.com, bms.com, bms.com, bms.com